US Supreme Court Human Genome Patents (Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 June 13, 2013 & now in Congress, the 'Patent Eligibility Restoration Act' of 2022/2023) to overturn patenting DNA decision
CRISPR | Jennifer Doudna | Why Is Jennifer Doudna Stating At the World Economic Forum, "Imagine That We Had a Tool Where We Could Fix Mutations In Actual DNA, a Text Editor for DNA and Cells?"